Stago Offers the Only Commercially Available Monoclonal Antibodies Anti-Human GPVI
2014/09/25: Glycoprotein VI (GPVI), a major collagen receptor playing a crucial role in collagen-induced platelet activation and aggregation, is a ~62-kDA type 1 transmembrane receptor belonging to the immunoglobulin superfamily.
Read more
Educational Resources from Diagnostica Stago: The Hemostasis Experts
September 9, 2013, Parsippany, NJ, USA – Diagnostica Stago Inc., offers expertise through two free electronic resources to educate healthcare professionals on hemostasis and thrombosis. The Stago-EdVantage web site and iHemOStasis app for the Apple® iPad® both offer ways to increase hemostasis knowledge, understand clinical situations, therapies and detection methods, and apply practical skills to patient care.
Read more
December 2013 - Essex Junction, Vermont – Haemtech Biopharma Services (HBS) is pleased to announce the successful validation of a thrombin generation assay (TGA) for an IVIG drug. The assay was validated in 2012 to support the use of TGA as a release assay for Biotest Pharmaceuticals Corporation’s U.S. Food and Drug Administration Biologics License Application for BIVIGAM® [Immune Globulin Intravenous (Human), 10% Liquid] product. The validated TGA assay was designed and performed on the Calibrated Automated Thrombogram® platform (CAT) from Diagnostica Stago, Inc. (Parsippany, NJ).
Read more
January 2014, Parsippany, NJ, USA – Diagnostica Stago Inc. announces launch of STA-Apixaban Calibrator and Controls for use with the STA® - Liquid Anti-Xa assay (catalog #s 00311US and 00322US). The bar-coded, automation-ready calibrators and controls expand the utility of STA® - Liquid Anti-Xa for specific measurement of apixaban activity in plasma for research purposes. The chromogenic STA® - Liquid Anti-Xa with STA® – Apixaban Calibrator and Controls has demonstrated excellent analytical performance with respect to sensitivity, dynamic range of the assay, inter-subject variability and coefficient of variation (CV).1,2,3
Read more
Stago Launches New Research Product for Antiplatelet Drug Testing
January 2014, Parsippany, NJ, USA – Diagnostica Stago Inc. introduces Cy-Quant VASP/P2Y12 (cat # 01076) for examination of platelet responsiveness to specific platelet ADP receptor (P2Y12) antagonists and their in vitro effects in fresh human whole blood. Cy-Quant VASP/P2Y12 is an enzyme-linked immunosorbent assay (ELISA) that can be used with any plate reader reporting 450 nm wavelengths.
Read more